INVESTORS
COMPANY INFORMATION
Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions across medical and industrial applications.
CORPORATE PRESENTATION
Medigus Corporate Presentation 2016
LATEST NEWS
Live Procedure in Germany Highlights Benefits and Ease-of-Use of MUSE™ to Top Endoscopists in Europe; Renowned gastroenterologists, Professors Messmann and Neuhaus, demonstrate transoral fundoplication with Medigus’ MUSE at Endo-Update in Germany
Medigus today announced the completion of a live transoral fundoplication (TF) procedure using the Medigus Ultrasonic Surgical Endostapler (MUSE™) system.
Medigus Announces a Notice of Intention to Grant a European Patent for Its micro ScoutCam™ Microvisual Technology
Medigus Ltd. announced today that it has received a Notice of Intention to Grant a Patent from the European Patent Office (EPO) for its micro ScoutCam™ miniature camera technology.
Medigus Announces Pricing of Registered Direct
Medigus Ltd. today announced that it has entered into a definitive agreement with institutional investors providing for the issuance of 1,139,170 American depositary shares (ADS) at a purchase price per ADS of $0.67 in a registered direct offering.
Medigus Announces Third Quarter 2016 Financial Results
Medigus Ltd. today announced financial results for the third quarter ended September 30, 2016.
